Browsing by Keyword : Thiazolidinediones

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 21 of 21

Pub YearTitleAJOU Author(s)
200315d-PGJ2 and rosiglitazone suppress Janus kinase-STAT inflammatory signaling through induction of suppressor of cytokine signaling 1 (SOCS1) and SOCS3 in glia.박은정, 조은혜, 주일로
2022A Real-World Study of Long-Term Safety and Efficacy of Lobeglitazone in Korean Patients with Type 2 Diabetes Mellitus한승진
2017Anti-fibrogenic effect of PPAR-gamma agonists in human intestinal myofibroblasts신성재, 이광재, 이기명
2017Cardiovascular events associated with second-line anti-diabetes treatments: analysis of real-world Korean data김대중, 하경화
2020Cell cycle synchronisation using thiazolidinediones affects cellular glucose metabolism and enhances the therapeutic effect of 2-deoxyglucose in colon cancer박복남, 변혜은, 안영실, 윤준기, 이수진
2007Depot-specific regulation of perilipin by rosiglitazone in a diabetic animal model.김대중, 김혜진, 이관우
2002Effects of peroxisome proliferator-activated receptor agonists on LPS-induced neuronal death in mixed cortical neurons: associated with iNOS and COX-2.문창현, 백은주, 이수환
2007Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus.김대중, 이관우
2011Fat redistribution preferentially reflects the anti-inflammatory benefits of pioglitazone treatment.김혜진
2017Impact of clinical evidence communications and drug regulation changes concerning rosiglitazone on prescribing patterns of antidiabetic therapies김대중, 이광재
2015Lobeglitazone and pioglitazone as add-ons to metformin for patients with type 2 diabetes: a 24-week, multicentre, randomized, double-blind, parallel-group, active-controlled, phase III clinical trial with a 28-week extension.이관우
2006Mitochondria are impaired in the adipocytes of type 2 diabetic mice.윤계순
2006Peroxisome proliferator-activated receptors-gamma activator, ciglitazone, inhibits human melanocyte growth through induction of apoptosis.강희영
2007PPAR-gamma agonist, ciglitazone, increases pigmentation and migration of human melanocytes.강희영
2005Predictive clinical parameters for therapeutic efficacy of rosiglitazone in Korean type 2 diabetes mellitus.김대중
2019Second-line glucose-lowering drugs added to metformin and the risk of hospitalization for heart failure: A nationwide cohort study김대중, 하경화
2006The 11482G >A polymorphism in the perilipin gene is associated with weight gain with rosiglitazone treatment in type 2 diabetes.김혜진
2007The different mechanisms of insulin sensitizers to prevent type 2 diabetes in OLETF rats.김대중
2007The increase in abdominal subcutaneous fat depot is an independent factor to determine the glycemic control after rosiglitazone treatment.김혜진
2006The long-term effects of rosiglitazone on serum lipid concentrations and body weight.김혜진
2016Troglitazone Stimulates Cancer Cell Uptake of 18F-FDG by Suppressing Mitochondrial Respiration and Augments Sensitivity to Glucose Restriction이수진
1

Browse